Apr 21, 2025 06:36AM
Apr 21, 2025 06:30AM
Mar 4, 2025 09:05AM
Mar 4, 2025 09:01AM
Mar 4, 2025 09:01AM
Feb 6, 2025 04:16PM
Feb 6, 2025 04:15PM Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
Dec 10, 2024 04:50PM
Aug 22, 2024 07:00AM
Aug 19, 2024 08:20AM
Aug 13, 2024 04:00PM
Sep 13, 2023 04:44AM
Sep 6, 2023 07:00AM
May 30, 2023 01:26PM Acelyrin (SLRN) risk/reward 'skewed to the upside'
May 30, 2023 10:05AM
May 9, 2023 04:10PM

211,042 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All